Cell and gene therapy represents a totally different paradigm for biomanufacturers, complete with its own challenges. Very careful orchestration of the supply chain network is necessary to manage the unique elements of patients, health care providers and blood into the supply chain and the impact they have on real-time rescheduling within the manufacturing environment. Watch the short video below to see some key considerations.